Disease, Pathogenicity, and Epidemiology

Resident Flora (Normal Flora)

The resident flora refers to the population of microorganisms that normally inhabit various parts of the human body without causing disease under normal circumstances.

• Definition: Resident flora are the microbes that colonize the body and are usually beneficial or harmless.

• Locations: Commonly found on the skin, oral cavity, gastrointestinal tract, upper respiratory tract, and urogenital tract.

• Absent Areas: Internal organs (e.g., heart, liver, kidneys), blood, cerebrospinal fluid, and lower respiratory tract typically do not have resident flora due to protective barriers.

• Clinical Importance: Knowledge of resident flora helps clinical microbiologists distinguish between normal and pathogenic microbes, aiding in diagnosis and treatment.

Benefits of Normal Flora

Normal flora play a crucial role in maintaining health and preventing disease.

• Competitive Exclusion: They compete with pathogens for nutrients and space, reducing the risk of infection.

• Immune Stimulation: Stimulate the immune system to remain active and responsive.

• Production of Essential Compounds: Some produce vitamins (e.g., vitamin K in the gut).

Pathogen Entry and Disease Causation

Pathogens must overcome several barriers to cause disease in a host.

• Portal of Entry: Pathogens enter the body through specific sites (e.g., skin breaks, respiratory tract, gastrointestinal tract).

• Colonization: Must adhere to host tissues and multiply.

• Invasion and Evasion: Must evade host defenses and invade tissues.

• Damage: Cause actual disease by damaging host cells or tissues.

• Example: Streptococcus pyogenes enters via the throat, adheres, evades immune response, and causes strep throat.

Virulence Factors

Virulence factors are molecules produced by pathogens that enhance their ability to cause disease.

• Definition: Traits that enable a microbe to invade and damage host tissues.

• Examples:

  • Toxins: e.g., botulinum toxin from Clostridium botulinum

  • Adhesins: e.g., fimbriae in Escherichia coli

  • Capsules: e.g., polysaccharide capsule in Streptococcus pneumoniae

Endotoxins vs. Exotoxins

Endotoxins and exotoxins are two major classes of bacterial toxins.

• Endotoxins: Components of the outer membrane of Gram-negative bacteria (lipopolysaccharide, LPS). Released upon cell death. Cause fever and shock.

• Exotoxins: Proteins secreted by both Gram-positive and Gram-negative bacteria. Highly specific and potent (e.g., tetanus toxin).

• Comparison Table:

Stages of Infection

Infectious diseases progress through distinct stages.

• Incubation Period: Time between entry and appearance of symptoms.

• Prodromal Stage: Early, mild symptoms.

• Acute Stage: Peak of symptoms and pathogen multiplication.

• Convalescence: Recovery and decline of symptoms.

Reservoirs vs. Transmission

A reservoir is the natural habitat of a pathogen; transmission is the process by which it spreads.

• Reservoirs: Humans, animals, environment (e.g., water, soil).

• Transmission: Direct contact, airborne, vector-borne, etc.

• Example: Salmonella reservoir is poultry; transmission is via contaminated food.

Biological vs. Mechanical Vectors

Vectors are organisms that transmit pathogens between hosts.

• Biological Vector: Pathogen develops or multiplies within the vector (e.g., mosquito for malaria).

• Mechanical Vector: Vector physically carries pathogen without development (e.g., housefly on food).

Public Health and Epidemiology

Public health laboratories and agencies track and prevent infectious diseases.

• CDC: Centers for Disease Control and Prevention monitors disease trends, outbreaks, and provides guidelines.

• Key Terms:

  • Morbidity Rate: Number of cases of disease in a population.

  • Mortality Rate: Number of deaths due to disease.

  • Case Reporting: Systematic documentation of disease cases.

  • Pandemic: Worldwide epidemic.

  • Epidemic: Sudden increase in cases in a region.

  • Endemic: Constant presence of disease in a population.

Immunology

Primary Barriers (First Line of Defense)

The first line of defense consists of physical and chemical barriers that prevent pathogen entry.

• Skin: Acts as a physical barrier.

• Mucous Membranes: Trap and expel microbes.

• Chemical Barriers: Lysozyme in tears, acidic pH in stomach.

Non-Specific vs. Specific Immune Response

The immune system has two major components: non-specific (innate) and specific (adaptive) responses.

• Non-Specific (Second Line): Includes phagocytes, inflammation, fever, complement system.

• Specific (Third Line): Involves lymphocytes (B cells and T cells), antibodies, and memory cells.

• Example: Phagocytosis (innate) vs. antibody production (adaptive).

Complement System Activation

The complement system can be activated by different pathways, leading to pathogen destruction.

• Classical Pathway: Triggered by antibodies bound to antigens.

• Alternative Pathway: Activated directly by pathogen surfaces.

• Results: Opsonization, inflammation, and cell lysis.

Humoral vs. Cell-Mediated Immunity

These are two branches of the adaptive immune system.

• Humoral Immunity: Mediated by B cells and antibodies; targets extracellular pathogens.

• Cell-Mediated Immunity: Mediated by T cells; targets intracellular pathogens (e.g., viruses).

Clonal Selection

Clonal selection is the process by which specific lymphocytes are activated and proliferate in response to an antigen.

• Activation: Antigen binds to a specific lymphocyte receptor.

• Result: Production of clones that target the antigen.

Antibodies (Immunoglobulins)

Antibodies are proteins produced by B cells that bind to specific antigens.

• Structure: Y-shaped molecules with variable regions for antigen binding.

• Function: Neutralize pathogens, opsonize for phagocytosis, activate complement.

• Types: IgG, IgM, IgA, IgE, IgD.

Vaccines and Immunoglobulins

Vaccines stimulate immunity; immunoglobulins can be used therapeutically.

• Vaccines: Induce active immunity by exposing the immune system to antigens.

• Immunoglobulin (Antitoxin): Passive immunity; used to neutralize toxins.

Direct vs. Indirect Tests

Laboratory tests can detect pathogens or antibodies.

• Direct Tests: Detect the pathogen itself (e.g., antigen detection).

• Indirect Tests: Detect antibodies produced in response to infection.

ELISA, FAT, and Agglutination Tests

These are common immunological assays used in diagnostics.

• ELISA (Enzyme-Linked Immunosorbent Assay): Detects antigens or antibodies using enzyme-linked reactions.

• FAT (Fluorescent Antibody Test): Uses fluorescent-labeled antibodies to detect antigens.

• Agglutination Tests: Detect antibodies or antigens by visible clumping.

Specimen Collection and Handling

Proper specimen collection, handling, and transport are essential for accurate laboratory diagnosis.

• Collection: Use sterile techniques to avoid contamination.

• Handling: Maintain appropriate temperature and conditions.

• Transport: Use suitable containers and timely delivery to the lab.

Antimicrobial Drugs

Laboratory Information for Physicians

Laboratories provide information beyond pathogen identification, such as drug susceptibility and resistance patterns.

• Susceptibility Testing: Determines which antibiotics are effective.

• Resistance Mechanisms: Identifies resistance genes or traits.

Minimum Inhibitory Concentration (MIC)

MIC is the lowest concentration of an antimicrobial that inhibits visible growth of a microorganism.

• Determination: Serial dilution method; observe growth inhibition.

• Equation:

Narrow vs. Broad Spectrum Antibiotics

Antibiotics are classified based on the range of organisms they affect.

• Narrow Spectrum: Effective against specific groups (e.g., penicillin for Gram-positive bacteria).

• Broad Spectrum: Effective against a wide range (e.g., tetracycline for Gram-positive and Gram-negative).

• Preference: Narrow spectrum preferred to minimize disruption of normal flora and resistance development.

Choosing Antibiotics: Key Considerations

• Pathogen Identity

• Drug Susceptibility

• Patient Factors: Allergies, age, pregnancy, organ function

• Drug Pharmacokinetics: Absorption, distribution, metabolism, excretion

Prokaryotic vs. Eukaryotic Cells: Drug Targets

Antibiotics exploit differences between prokaryotic and eukaryotic cells.

• Cell Wall: Present in bacteria, absent in humans.

• Ribosomes: 70S in bacteria, 80S in humans.

• Metabolic Pathways: Unique bacterial enzymes.

Antifungal and Antiviral Drug Challenges

Developing non-toxic drugs for fungal and viral infections is difficult due to similarities with host cells and viral reliance on host machinery.

• Antifungal Drugs: Fungi are eukaryotic, so fewer unique targets.

• Antiviral Drugs: Viruses use host cell machinery, making selective targeting challenging.

• Antibiotics: Ineffective against viruses due to lack of bacterial structures.

Additional info: These study notes expand on the question prompts by providing definitions, examples, and context for key microbiology concepts relevant to college-level coursework.